JP Morgan Chase’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-129,906
Closed -$432K 6202
2020
Q3
$432K Buy
129,906
+3,395
+3% +$10.8K ﹤0.01% 4046
2020
Q2
$368K Sell
126,511
-26,782
-17% -$84.7K ﹤0.01% 3979
2020
Q1
$432K Buy
153,293
+26,023
+20% +$83.9K ﹤0.01% 3886
2019
Q4
$413K Sell
127,270
-637,799
-83% -$1.85M ﹤0.01% 4331
2019
Q3
$1.65M Buy
765,069
+632,294
+476% +$1.69M ﹤0.01% 3538
2019
Q2
$405K Buy
132,775
+5,257
+4% +$17.1K ﹤0.01% 4333
2019
Q1
$474K Sell
127,518
-81,665
-39% -$276K ﹤0.01% 4235
2018
Q4
$606K Sell
209,183
-45,013
-18% -$124K ﹤0.01% 4031
2018
Q3
$669K Buy
254,196
+115,956
+84% +$285K ﹤0.01% 4135
2018
Q2
$323K Sell
138,240
-93,976
-40% -$262K ﹤0.01% 4364
2018
Q1
$683K Sell
232,216
-349,364
-60% -$954K ﹤0.01% 3877
2017
Q4
$1.59M Sell
581,580
-165,036
-22% -$507K ﹤0.01% 3447
2017
Q3
$2.54M Sell
746,616
-477,042
-39% -$1.33M ﹤0.01% 3018
2017
Q2
$3.02M Sell
1,223,658
-549,767
-31% -$1.26M ﹤0.01% 2803
2017
Q1
$4.03M Buy
1,773,425
+236,745
+15% +$524K ﹤0.01% 2585
2016
Q4
$3.26M Buy
1,536,680
+1,318,714
+605% +$3.68M ﹤0.01% 2760
2016
Q3
$730K Sell
217,966
-22,973
-10% -$72.9K ﹤0.01% 3262
2016
Q2
$757K Buy
240,939
+10,685
+5% +$35.6K ﹤0.01% 3281
2016
Q1
$767K Buy
230,254
+11,747
+5% +$36.6K ﹤0.01% 3172
2015
Q4
$774K Sell
218,507
-80,237
-27% -$336K ﹤0.01% 3226
2015
Q3
$1.5M Sell
298,744
-2,717
-0.9% -$15.6K ﹤0.01% 2894
2015
Q2
$1.94M Sell
301,461
-459,312
-60% -$3.08M ﹤0.01% 2930
2015
Q1
$5.35M Sell
760,773
-490,586
-39% -$3.55M ﹤0.01% 2302
2014
Q4
$9.65M Buy
1,251,359
+487,499
+64% +$3.86M ﹤0.01% 1979
2014
Q3
$5.71M Buy
763,860
+464,655
+155% +$4.31M ﹤0.01% 2280
2014
Q2
$2.9M Buy
299,205
+209,371
+233% +$1.87M ﹤0.01% 2351
2014
Q1
$747K Sell
89,834
-811,436
-90% -$6.95M ﹤0.01% 2980
2013
Q4
$7.61M Sell
901,270
-192,167
-18% -$1.62M ﹤0.01% 1919
2013
Q3
$8.71M Buy
1,093,437
+46,544
+4% +$374K ﹤0.01% 1840
2013
Q2
$8.08M Buy
+1,046,893
New +$8.16M ﹤0.01% 1814

Other funds holding PDLI